BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2989471)

  • 21. Human parvovirus, the cause of erythema infectiosum (fifth disease)?
    Anderson MJ; Jones SE; Fisher-Hoch SP; Lewis E; Hall SM; Bartlett CL; Cohen BJ; Mortimer PP; Pereira MS
    Lancet; 1983 Jun; 1(8338):1378. PubMed ID: 6134148
    [No Abstract]   [Full Text] [Related]  

  • 22. Erythema infectiosum in a primary school: investigation of an outbreak in Bury.
    Turner A; Olojugba O
    Public Health; 1989 Sep; 103(5):391-3. PubMed ID: 2552489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Erythema infectiosum, the fifth disease--an epidemiologic outbreak in Overum 1983].
    Fridell E; Levin R; Grandien M
    Lakartidningen; 1984 Aug; 81(34):2916-9. PubMed ID: 6088915
    [No Abstract]   [Full Text] [Related]  

  • 24. Risk of adverse outcomes of pregnancy after human parvovirus B19 infection.
    Kinney JS; Anderson LJ; Farrar J; Strikas RA; Kumar ML; Kliegman RM; Sever JL; Hurwitz ES; Sikes RK
    J Infect Dis; 1988 Apr; 157(4):663-7. PubMed ID: 2831283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Association of non-immunologically-induced hydrops fetalis with Parvovirus B19 infection].
    Schwarz TF; Roggendorf M; Simader R
    Geburtshilfe Frauenheilkd; 1987 Aug; 47(8):572-3. PubMed ID: 2820831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence of antibody to human parvovirus B19 in Rio de Janeiro, Brazil.
    Nascimento JP; Buckley MM; Brown KE; Cohen BJ
    Rev Inst Med Trop Sao Paulo; 1990; 32(1):41-5. PubMed ID: 2175446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythema infectiosum and other parvovirus B19 infections.
    Kirchner JT
    Am Fam Physician; 1994 Aug; 50(2):335-41. PubMed ID: 8042568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rheumatologic manifestations of human parvovirus B19 infection in adults. Initial two-year clinical experience.
    Naides SJ; Scharosch LL; Foto F; Howard EJ
    Arthritis Rheum; 1990 Sep; 33(9):1297-309. PubMed ID: 2169746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human parvovirus and thalassaemia.
    Lefrere JJ; Courouce AM; Girot R; Cornu P
    J Infect; 1986 Jul; 13(1):45-9. PubMed ID: 3016099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis.
    Weissbrich B; Süss-Fröhlich Y; Girschick HJ
    Arthritis Res Ther; 2007; 9(4):R82. PubMed ID: 17760961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence of parvovirus B19 among HIV-1-positives in Japan.
    Taguchi H; Yamada T; Takahashi T; Gotoh M; Nakamura T; Iwamoto A
    Jpn J Infect Dis; 2000 Feb; 53(1):21. PubMed ID: 10777855
    [No Abstract]   [Full Text] [Related]  

  • 32. The seroprevalence of parvovirus B19 infection among to-be-married girls, pregnant women, and their neonates in Shiraz, Iran.
    Ziyaeyan M; Rasouli M; Alborzi A
    Jpn J Infect Dis; 2005 Apr; 58(2):95-7. PubMed ID: 15858287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parvovirus B19 antibodies and correlates of infection in pregnant women attending an antenatal clinic in central Nigeria.
    Emiasegen SE; Nimzing L; Adoga MP; Ohagenyi AY; Lekan R
    Mem Inst Oswaldo Cruz; 2011 Mar; 106(2):227-31. PubMed ID: 21537685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a synthetic-peptide enzyme-linked immunosorbent assay for immunoglobulin M to human parvovirus B19.
    Fridell E; Cohen BJ; Wahren B
    J Clin Microbiol; 1991 Jul; 29(7):1376-81. PubMed ID: 1653264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectrum of parvovirus B19 infection: analysis of an outbreak of 43 cases in Cadiz, Spain.
    García-Tapia AM; Fernandez-Gutiérrez del Alamo C; Girón JA; Mira J; de la Rubia F; Martínez-Rodríguez A; Martín-Reina MV; López-Caparros R; Cáliz R; Caballero MS
    Clin Infect Dis; 1995 Dec; 21(6):1424-30. PubMed ID: 8749627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Parvovirus B19 infections in Germany 1987-1988].
    Schwarz TF; Jäger G; Schlipköter UA; Wiersbitzky S; Tiller FW; Hottenträger B; Deinhardt F; Roggendorf M
    Offentl Gesundheitswes; 1990 Feb; 52(2):53-7. PubMed ID: 2158028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parvovirus B19 infection in children with acute illness and rash.
    Pruksachatkunakorn C; Apichartpiyakul N; Kanjanaratanakorn K
    Pediatr Dermatol; 2006; 23(3):216-8. PubMed ID: 16780465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Investigation of parvovirus B19 seroprevalence in various age groups in Central Anatolia Region, Turkey].
    Türk Dağı H; Ozdemir M; Baykan M; Baysal B
    Mikrobiyol Bul; 2010 Jul; 44(3):467-72. PubMed ID: 21063997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory infection with human parvovirus B19.
    Shiraishi H; Sasaki T; Nakamura M; Yaegashi N; Sugamura K
    J Infect; 1991 May; 22(3):308-10. PubMed ID: 1649224
    [No Abstract]   [Full Text] [Related]  

  • 40. Erythema infectiosum (fifth disease).
    Chorba T; Anderson LJ
    Clin Dermatol; 1989; 7(1):65-74. PubMed ID: 2538215
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.